Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kerrick Hesse"'
Publikováno v:
Heart Views, Vol 24, Iss 3, Pp 141-147 (2023)
Background: Clinical equipoise between a percutaneous coronary intervention (PCI) and coronary artery bypass grafting surgery (CABG) in the treatment of complex coronary artery disease (CAD), including unprotected left main coronary artery (LMCA) and
Externí odkaz:
https://doaj.org/article/e70e907c10a740e4b812cdbaca4489ae
Autor:
Kerrick Hesse
Publikováno v:
American Heart Journal Plus, Vol 23, Iss , Pp 100218- (2022)
The rates of atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) continue to grow with many patients suffering from their combined impact on quality of life and prognosis.A lower heart rate (HR) in HFrEF is associated wi
Externí odkaz:
https://doaj.org/article/f0b51f58737d4f729e251d8c918e0398
Autor:
Kerrick Hesse, Farhan Shahid, Raheel Ahmed, Faizan Ahmed, Timothy R.G. Cartlidge, Muhammad Rashid, Mamas A. Mamas, Gary S. Mintz, Javed M. Ahmed
Publikováno v:
Cardiovascular Revascularization Medicine.
Publikováno v:
Respiratory Medicine. 196:106800
Patients surviving hospitalization for exacerbations of chronic obstructive pulmonary disease (ECOPD) are at heightened risk of cardiovascular events. Heart failure is often underdiagnosed and undertreated in COPD; better care could improve outcome.
Publikováno v:
The Surgeon. 14:136-141
Introduction Due to the rising disparity between demand and availability, organs from expanded criteria donors (ECD) and donors after determination of circulatory death (DCD) are increasingly used. The purpose of this study was to report outcomes in
Autor:
Kerrick Hesse, Rachael L. MacIsaac, Azmil H. Abdul-Rahim, Patrick D. Lyden, Erich Bluhmki, Kennedy R. Lees, A. Alexandrov, P.M. Bath, N. Bornstein, L. Claesson, S.M. Davis, G. Donnan, H.C. Diener, M. Fisher, B. Gregson, J. Grotta, W. Hacke, M.G. Hennerici, M. Hommel, M. Kaste, J. Marler, K. Muir, R. Sacco, A. Shuaib, P. Teal, N.G. Wahlgren, S. Warach, C. Weimar
Publikováno v:
Stroke. 47:882-885
Background and Purpose— Knowing characteristic adverse events (AEs) and their incidence among patients participating in acute stroke trials may assist interpretation of future studies. We aimed to develop an online tool to inform stroke trial safet
Autor:
Keith W. Muir, S. Warach, M. Kaste, M.G. Hennerici, Azmil H. Abdul-Rahim, L. Claesson, W. Hacke, H.C. Diener, Patrick D. Lyden, J. Marler, P.W. Bath, A. Shuaib, R.L. Sacco, J. Curram, M. Fisher, Rachael L. Fulton, C. Weimar, N.G. Wahlgren, Kennedy R. Lees, B. Gregson, G. Donnan, P. Teal, M. Hommel, Stephen M. Davis, J. Grotta, Kerrick Hesse, A.V. Alexandrov, E. Bluhmki
Publikováno v:
Stroke. 45:2677-2682
Background and Purpose— Adverse events (AE) in trial populations present a major burden to researchers and patients, yet most events are unrelated to investigational treatment. We aimed to develop a coherent list of expected AEs, whose incidence ca